Work

Assessment of the Effectiveness of the Clinical and Pharmacoeconomic Aspects of Topamax in Patients With Epilepsy

Year: 2023

Type: article

Abstract: This scientific article concerns epilepsy, a disease widespread in medicine, which is one of the common diseases of the nervous system requiring long-term treatment. According to the statistical data of the European Commission on epilepsy, about 50 million people in the world suffer from epilepsy. The development of epilepsy is caused by hereditary and genetic factors and, following traumas and infectious diseases, by perinatal damage to the brain. At present, the number of patients with epilepsy in European countries is increasing.

Source: Research Focus International Scientific Journal

DOI: 10.66073/researchfocus.v2i5.247

Authors: Arslonova Rayxon Rajabboevna, Narmetova Sevara Yangiboyevna

Institution: Samarkand State Medical Institute

Language: English

Topic: Epilepsy research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7210266654

FWCI:

Cites: 1

Cited by:

Related to: 10